Growth Opportunities in the Tissue Diagnostics Industry 2024-2029: Multiomics Analysis for Precision Diagnostics, Comprehensive Diagnostic Panels for Early Identification of Cancer Biomarkers
02 oct. 2024 07h04 HE
|
Research and Markets
Dublin, Oct. 02, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024-2029" report has been added to ResearchAndMarkets.com's offering.The global...
Precision Diagnostics Market Size Expected to Reach USD 224.53 Billion by 2032 with a CAGR of 13.50% - SNS Insider
24 sept. 2024 09h00 HE
|
SNS Insider pvt ltd
Pune, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Precision Diagnostics Market Size & Growth Analysis: The Precision Diagnostics Market size was valued at USD 75.87 billion in 2023 and is projected to...
Preeclampsia Diagnostics Market Projected to Reach $1.211 Billion by 2029: Efforts to Boost Awareness and Diagnostic Accessibility Boosts Expansion
16 août 2024 07h20 HE
|
Research and Markets
Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Preeclampsia Diagnostics Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. The prevalence of...
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
12 août 2024 16h10 HE
|
OncoCyte Corporation
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
08 août 2024 16h05 HE
|
OncoCyte Corporation
Oncocyte Announces Successful GraftAssureTM Beta Launch and Q2 2024 Results
Oncocyte Announces August Investor Conferences Participation
05 août 2024 16h05 HE
|
OncoCyte Corporation
Oncocyte Announces August Investor Conferences Participation
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
01 août 2024 16h05 HE
|
OncoCyte Corporation
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
30 mai 2024 16h47 HE
|
OncoCyte Corporation
Late-breaking presentation of data at American Transplant Congress on Monday, June 3Data show potential to monitor for therapeutic efficacy and recurrencePotential repeat testing opportunities with...
Oncocyte Reports First Quarter 2024 Financial Results
15 mai 2024 16h05 HE
|
OncoCyte Corporation
ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
Oncocyte to Announce First Quarter 2024 Financial Results
13 mai 2024 08h00 HE
|
OncoCyte Corporation
Oncocyte to Announce First Quarter 2024 Financial Results